Patient Controlled Injectors Market Size, Share, Demand & Trends Analysis Report 2026

Patient Controlled Injectors Market

Patient Controlled Injectors Market – By Application (Cancer Treatment, Auto-immune Treatment, and Blood Disorders Treatment), By Product (Electronic Wearable Injectors, Mechanical Wearable Injectors, and Infusion Pumps), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Category: Medical Device Report Format : PDF Pages: 130 Report Code: ZMR-6204 Published Date: May-2021 Status : Published
Market Size in 2019 Market Forecast in 2026 CAGR (in %) Base Year
USD 2,969 Million USD 6,579 Million 12.1% 2019

Patient Controlled Injectors Market

Patient Controlled Injectors Market Size And Industry Analysis

The Global Patient Controlled Injectors Market Size which was estimated at about 2,969 USD Million in 2019 and is predicted to accrue earnings worth 6,579 USD Million by 2026, is set to record a CAGR of nearly over 12.1% during 2020-2026. The report offers valuation and analysis of Patient Controlled Injectors market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2019 along with a forecast from 2020 to 2026 based on value USD Million.

Patient Controlled Injectors Market: An Overview

Patient controlled injector is the breakthrough in injection administration. The medical device helps in fulfilling the unmet requirements of patients as it offers comfort and ease as compared to any other medical equipment. Moreover, the device is ergonomically created and helps in patient in improving self-care, thereby making it easier for the patients in effectively handling & administering the medicines at a prescribed period. Apart from this, the medical device is a subcutaneous drug delivery tool adhering to the patient body along with helping in inoculating huge volumes of medicine.

Global Patient Controlled Injectors MarketRequest Free Sample

Patient Controlled Injectors Market: Growth Drivers

Escalating occurrence of chronic ailments such as autoimmune diseases, cancer, and blood ailments resulting in need for elongate duration of treatment will prompt the growth of patient controlled injectors industry over the assessment period. In addition to this, utility of patient controlled injectors has assisted in mitigating risks of contamination, needle stick injuries, and reducing medical errors caused as a result of parenteral mode of medicine administration through injection. This, in turn, will promulgate the expansion of patient controlled injectors industry over the upcoming years.

Breakthroughs in pharma sector resulting in launching of new drug therapies for treating severe disorders will translate into massive demand for patient controlled injectors across the healthcare industry over 2020-2026. Apparently, patient controlled injector provides efficient target drug delivery along with long-term medicine residence to affected regions of heart systems, thereby enhancing the popularity of the product in the recent years.

Patient Controlled Injectors Market: Report Scope

Report Attributes Report Details
Report Name Patient Controlled Injectors Market Research Report
Market Size in 2019 USD 2,969 Million
Market Forecast in 2026 USD 6,579 Million
Growth Rate CAGR of 12.1%
Number of Pages 130
Key Companies Covered Gerresheimer AG, scPharmaceuticals Inc., United Therapeutics Corporation, Westbourne Medical Limited, Enable Injections, Johnson and Johnson Services, Inc., F. Hoffmann-La Roche Ltd., BD, and Ypsomed AG.
Segments Covered By Application, By Product, By Distribution Channel, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2019
Historical Year 2017 to 2019
Forecast Year 2020 - 2026
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

North America To Make Notable Contributions Towards Overall Market Share By 2026

The regional market growth over 2020-2026 is due to surge in the chronic ailment occurrence requiring patient controlled injectors for inoculating medicines. In addition to this, presence of major participants profiled in the study will drive the regional market trends.

Some of the leading players in the global market inlcude

  • Gerresheimer AG
  • scPharmaceuticals Inc.
  • United Therapeutics Corporation
  • Westbourne Medical Limited
  • Enable Injections
  • Johnson and Johnson Services Inc.
  • F. Hoffmann-La Roche Ltd.
  • BD
  • Ypsomed AG.

The global Patient Controlled Injectors Market is segmented as follows:

By Application:

  • Cancer Treatment
  • Auto-immune Treatment
  • Blood Disorders Treatment

By Product:

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Escalating occurrence of chronic ailments such as autoimmune diseases, cancer, and blood ailments resulting in need for elongate duration of treatment will prompt the growth of patient controlled injectors industry over the assessment period. In addition to this, utility of patient controlled injectors has assisted in mitigating risks of contamination, needle stick injuries, and reducing medical errors caused as a result of parenteral mode of medicine administration through injection. This, in turn, will promulgate the expansion of patient controlled injectors industry over the upcoming years. Breakthroughs in pharma sector resulting in launching of new drug therapies for treating severe disorders will translate into massive demand for patient controlled injectors across the healthcare industry over 2020-2026. Apparently, patient controlled injector provides efficient target drug delivery along with long-term medicine residence to affected regions of heart systems, thereby enhancing the popularity of the product in the recent years.

According to Zion Market Research report, the global Patient Controlled Injectors market, which was estimated at about 2,969 (USD Million) in 2019 and is predicted to accrue earnings worth 6,579 (USD Million) by 2026, is set to record a CAGR of nearly over 12.1% during 2020-2026.  

North America is likely to make noteworthy contributions towards overall market revenue. The growth of the industry in the sub-continent over the estimated timespan is attributed to surge in the chronic ailment occurrence requiring patient controlled injectors for inoculating medicines. In addition to this, presence of major participants profiled in the study will drive the regional market trends.

The key players profiled in the report include are Gerresheimer AG, scPharmaceuticals Inc., United Therapeutics Corporation, Westbourne Medical Limited, Enable Injections, Johnson and Johnson Services, Inc., F. Hoffmann-La Roche Ltd., BD, and Ypsomed AG.

 

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed